The systemic exposure in children in comparison to adolescents was equivalent for formoterol while it was halved for beclometasone-17-monopropionate in accordance with the halved dose of beclometasone administered in children ( 90 % CIs within 0.8-1 .25 for formoterol and 0.4-0 .625 for beclometasone-17-monopropionate ) .